Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common shares, no par value
-
Shares outstanding
-
25,378,604
-
Total 13F shares
-
3,051,629
-
Share change
-
+1,536,718
-
Total reported value
-
$11,352,061
-
Price per share
-
$3.72
-
Number of holders
-
7
-
Value change
-
+$5,738,203
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) as of Q1 2025
As of 31 Mar 2025,
Medicus Pharma Ltd. - Common shares, no par value (MDCX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,051,629 shares.
The largest 7 holders included
Interchange Capital Partners, LLC, ARMISTICE CAPITAL, LLC, Private Advisor Group, LLC, PATRIOT INVESTMENT MANAGEMENT GROUP, INC., UBS Group AG, Base Wealth Management LLC, and OSAIC HOLDINGS, INC..
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.